Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Allylation Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Novel axial chiral phosphine-ene ligand enables mild-condition asymmetric allylation with high yield and enantioselectivity, ensuring reliable supply chain for pharmaceutical intermediates.